Haferlach, C., Mecucci, C., Schnittger, S., Kohlmann, A., Mancini, M., Cuneo, A., Testoni, N., Rege-Cambrin, G., Santucci, A., Vignetti, M., Fazi, P., Martelli, M.P., Haferlach, T. and Falini, B. (2009) AML with Mutated NPM1 Carrying a Normal or Aberrant Karyotype Show Overlapping Biologic, Pathologic, Immunophenotypic, and Prognostic Features. Blood, 114, 3024-3032.
http://dx.doi.org/10.1182/blood-2009-01-197871

has been cited by the following article:

• TITLE: Histone Chaperones: Functions beyond Nucleosome Deposition

  AUTHORS: Divya Reddy, Saikat Bhattacharya, Sanjay Gupta

  KEYWORDS: Histones, Chromatin, Cancer, Therapeutic Target

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.5 No.6, May 23, 2014

  ABSTRACT: Histones, the structural unit of chromatin, must be assembled/dissembled to preserve or change chromatin organization in accordance to cellular needs. Initially, function of histone chaperones was thought to be only “histone carriers/vehicles”, but now with accumulating evidences they are known to be the key actors of histone metabolism. With this outburst of knowledge, histone chaperones are now placed at the center of gene regulation, having roles to play in DNA replication, repair and transcription. This review will focus on the current knowledge we have about the role of histone chaperones in regulating cellular processes and their relation to disease. In addition, we discuss the potential of histone chaperones as a therapeutic target.